DZ Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

DZ Bank’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-213,000	Closed	-$98.9M	–	1046
2024 Q3	$98.9M	Hold	213,000	–	–	0.1%	132
2024 Q2	$101M	Hold	213,000	–	–	0.1%	124
2024 Q1	$89M	Hold	213,000	–	–	0.1%	135
2023 Q4	$86.5M	Hold	213,000	–	–	0.11%	126
2023 Q3	$74.4M	Hold	213,000	–	–	0.11%	120
2023 Q2	$75M	Hold	213,000	–	–	0.11%	114
2023 Q1	$66.8M	Buy	+213,000	New	+$63.9M	0.11%	127

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DZ Bank's VRTX Position: Q2 2026 in Review

DZ Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 1.4% in Q2 2026, selling an estimated $2.3M and leaving 359,332 shares worth $178M. The position accounts for 0.14% of the portfolio, ranked #116.

DZ Bank first reported a position in VRTX in Q4 2017 and has held it in 35 quarters since. The position peaked at $563M in Q3 2020. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

DZ Bank held 359,332 shares of Vertex Pharmaceuticals worth $178M as of Q2 2026.
DZ Bank sold 5,181 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.3M.
Vertex Pharmaceuticals made up 0.14% of DZ Bank's portfolio in Q2 2026, its #116 holding.
DZ Bank first reported a position in Vertex Pharmaceuticals in Q4 2017 and has held it in 35 quarters since.
DZ Bank's Vertex Pharmaceuticals position peaked at $563M in Q3 2020.
1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.